Related references
Note: Only part of the references are listed.DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort
Robert W. van Leeuwen et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype
Ann-Christin Frank et al.
NATURE COMMUNICATIONS (2019)
Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry
Asami Yagi et al.
CANCER RESEARCH (2019)
A three-gene methylation marker panel for the nodal metastatic risk assessment of muscle-invasive bladder cancer
Beatrice Stubendorff et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Cervical Cancer, Version 3.2019
Wui-Jin Koh et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy
Christoph Oing et al.
CANCER LETTERS (2018)
Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries
Hongmei Zeng et al.
LANCET GLOBAL HEALTH (2018)
Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma
Abderrahim Oussalah et al.
EBIOMEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Screening for Cervical Cancer US Preventive Services Task Force Recommendation Statement
Susan J. Curry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions
Marjolein van Zummeren et al.
MODERN PATHOLOGY (2018)
Hypermethylation of gene body CpG islands predicts high dosage of functional oncogenes in liver cancer
Maria Arechederra et al.
NATURE COMMUNICATIONS (2018)
Nanoformulation of Olaparib Amplifies PARP Inhibition and Sensitizes PTEN/TP53-Deficient Prostate Cancer to Radiation
Anne L. van de Ven et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and immunotherapies
Geraldine Genard et al.
FRONTIERS IN IMMUNOLOGY (2017)
The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6
Yuan Yin et al.
CLINICAL CANCER RESEARCH (2017)
Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer
Wina Verlaat et al.
CLINICAL CANCER RESEARCH (2017)
Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study
Andreas Schroeck et al.
CLINICAL CHEMISTRY (2017)
Global Cancer in Women: Burden and Trend
Lindsey A. Torre et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Tumor-Associated Macrophages Associate with Cerebrospinal Fluid Interleukin-10 and Survival in Primary Central Nervous System Lymphoma (PCNSL)
Takashi Sasayama et al.
BRAIN PATHOLOGY (2016)
Non-CG DNA methylation is a biomarker for assessing endodermal differentiation capacity in pluripotent stem cells
Lee M. Butcher et al.
NATURE COMMUNICATIONS (2016)
SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas
Alexander Semaan et al.
CLINICAL EPIGENETICS (2016)
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
Claudia Allemani et al.
LANCET (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Comparison of Genetic and Epigenetic Alterations of Primary Tumors and Matched Plasma Samples in Patients with Colorectal Cancer
Elisa Danese et al.
PLOS ONE (2015)
Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
Xiaojing Yang et al.
CANCER CELL (2014)
Comprehensive analysis of DNA methylation data with RnBeads
Yassen Assenov et al.
NATURE METHODS (2014)
Macrophage Regulation of Tumor Responses to Anticancer Therapies
Michele De Palma et al.
CANCER CELL (2013)
HMGB1 in Cancer: Good, Bad, or Both?
Rui Kang et al.
CLINICAL CANCER RESEARCH (2013)
Human papillomavirus and cervical cancer
Emma J. Crosbie et al.
LANCET (2013)
Intraoperative Electron Beam Radiotherapy (IOERT) in the management of locally advanced or recurrent cervical cancer
Brandon M. Barney et al.
RADIATION ONCOLOGY (2013)
On the presence and role of human gene-body DNA methylation
Daudi Jjingo et al.
ONCOTARGET (2012)
Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
Jorja D. Warren et al.
BMC MEDICINE (2011)
Replication timing-related and gene body-specific methylation of active human genes
Dvir Aran et al.
HUMAN MOLECULAR GENETICS (2011)
Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression
Diana Connolly et al.
BREAST CANCER RESEARCH (2011)
Quantitative DNA Methylation Analysis Detects Cervical Intraepithelial Neoplasms Type 3 and Worse
Hung-Cheng Lai et al.
CANCER (2010)
Blockade of Tumor Necrosis Factor α Signaling in Tumor-Associated Macrophages as a Radiosensitizing Strategy
Yuru Meng et al.
CANCER RESEARCH (2010)
Modern Radiotherapy and Cervical Cancer
Melanie E. B. Powell
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
Targeted Knockdown of SEPT9_ v1 Inhibits Tumor Growth and Angiogenesis of Human Prostate Cancer Cells Concomitant with Disruption of Hypoxia-Inducible Factor-1 Pathway
Sharon Amir et al.
MOLECULAR CANCER RESEARCH (2010)
High SEPT9_v1 Expression Is Associated with Poor Clinical Outcomes in Head and Neck Squamous Cell Carcinoma
Laura Stanbery et al.
TRANSLATIONAL ONCOLOGY (2010)
Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells
Madeleine P. Ball et al.
NATURE BIOTECHNOLOGY (2009)
HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIα
Michal Stros et al.
NUCLEIC ACIDS RESEARCH (2009)
Growth suppression and radiosensitivity increase by HMGB1 in breast cancer
Yang Jiao et al.
ACTA PHARMACOLOGICA SINICA (2007)
Increased expression of pAKT is associated with radiation resistance in cervical cancer
T-J Kim et al.
BRITISH JOURNAL OF CANCER (2006)
Altered patterns of transcription of the septin gene, SEPT9, in ovarian tumorigenesis
M Scott et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
MSF-A interacts with hypoxia-inducible factor-1α and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis
S Amir et al.
CANCER RESEARCH (2006)
Increased, expression of ICAM-3 is associated with radiation resistance in cervical cancer
YM Chung et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Mutations in SEPT9 cause hereditary neuralgic amyotrophy
G Kuhlenbäumer et al.
NATURE GENETICS (2005)
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
P Scaffidi et al.
NATURE (2002)
Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis
JA Green et al.
LANCET (2001)
Share Paper
